Marshall Wace
IMCR icon

Marshall Wace’s Immunocore IMCR Stock Holding History

Marshall Wace’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.8M Buy
590,941
+410,601
+228% +$12.1M 0.01% 753
2026
Q1 		$5.44M Buy
180,340
+119,177
+195% +$3.86M 0.01% 1266
2025
Q4 		$2.12M Sell
61,163
-62,079
-50% -$2.19M ﹤0.01% 1547
2025
Q3 		$4.48M Sell
123,242
-23,368
-16% -$794K ﹤0.01% 1229
2025
Q2 		$4.6M Buy
146,610
+118,728
+426% +$3.69M 0.01% 1182
2025
Q1 		$827K Sell
27,882
-728
-3% -$21.8K ﹤0.01% 1865
2024
Q4 		$844K Sell
28,610
-170,833
-86% -$5.4M ﹤0.01% 1812
2024
Q3 		$6.21M Sell
199,443
-49,211
-20% -$1.79M 0.01% 916
2024
Q2 		$8.43M Buy
248,654
+30,703
+14% +$1.57M 0.01% 811
2024
Q1 		$14.2M Buy
+217,951
New +$15M 0.02% 629
2023
Q4 		– Sell
-85,639
Closed -$4.44M – 2367
2023
Q3 		$4.44M Sell
85,639
-3,165
-4% -$187K 0.01% 918
2023
Q2 		$5.32M Buy
88,804
+64,684
+268% +$3.69M 0.01% 995
2023
Q1 		$1.19M Sell
24,120
-6,260
-21% -$352K ﹤0.01% 1729
2022
Q4 		$1.73M Buy
30,380
+6,260
+26% +$352K ﹤0.01% 1797
2022
Q3 		$1.13M Hold
24,120
– – ﹤0.01% 2347
2022
Q2 		$900K Hold
24,120
– – ﹤0.01% 2504
2022
Q1 		$721K Hold
24,120
– – ﹤0.01% 2603
2021
Q4 		$826K Buy
+24,120
New +$873K ﹤0.01% 2558

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Marshall Wace's IMCR Position: Q2 2026 in Review

Marshall Wace increased its Immunocore (IMCR) stake by 228% in Q2 2026, buying an estimated $12.1M and bringing the position to 590,941 shares worth $18.8M. The position accounts for 0.01% of the portfolio, ranked #753.

Marshall Wace first reported a position in IMCR in Q4 2021 and has held it in 18 quarters since. 135 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Marshall Wace held 590,941 shares of Immunocore worth $18.8M as of Q2 2026.
  • Marshall Wace bought 410,601 Immunocore shares in Q2 2026, an estimated $12.1M.
  • Immunocore made up 0.01% of Marshall Wace's portfolio in Q2 2026, its #753 holding.
  • Marshall Wace first reported a position in Immunocore in Q4 2021 and has held it in 18 quarters since.
  • 135 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.